US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant.

In this article, we are going to take a look at where Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) stands against other best ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ...

4 analysts have shared their evaluations of Enanta Pharma (NASDAQ:ENTA) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a concise ...

Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA ) shareholders should be happy to see the share price up 16% in the last... On September 30, 2024, Millennium Management LLC, a prominent hedge fund ...

Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results ...

On September 30, 2024, Millennium Management LLC, a prominent hedge fund, expanded its investment portfolio by acquiring 73,1295 shares of Enanta Pharmaceuticals Inc (NASDAQ:ENTA). This ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...